I'm with you POS. After the positive Rett results I never thought this SP territory would be revisited. There isn't even a bad trial result to cause it to drop it back nearly 50%. Plus there are 3 further top line results in 2nd half 2015.
The churning of these converted options is creating some brilliant buying opportunities leading up to the next run of results.
Ann: Annual Report to shareholders, page-25
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.09 |
Change
-0.710(3.26%) |
Mkt cap ! $2.693B | |||
| Open | High | Low | Value | Volume |
| $21.74 | $21.78 | $21.03 | $7.303M | 342.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 377 | $21.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.10 | 257 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.16 |
Change
-0.710 ( 3.28 %) |
||||
| Open | High | Low | Volume | ||
| $21.72 | $21.72 | $21.03 | 92331 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| NEU (ASX) Chart |